About Liposonix
Liposonix is a company based in Hayward (United States) founded in 1999 was acquired by Solta in September 2011. Liposonix has raised $37.94 million across 3 funding rounds from investors including The Carlyle Group, Solta and Pinnacle Ventures. The company has 6,139 employees as of December 31, 2021. Liposonix operates in a competitive market with competitors including Zeltiq, CoolSculpting, Nitinote Surgical, Standard Bariatrics and HourGlass Technologies, among others.
- Headquarter Hayward, United States
- Employees 6139 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bausch Health Companies Inc.
-
Annual Revenue
$9.52 B (USD)7832as on Dec 31, 2024
-
Net Profit
-$46 M (USD)-142as on Dec 31, 2024
-
EBITDA
$3.93 B (USD)154as on Dec 31, 2024
-
Total Equity Funding
$37.94 M (USD)
in 3 rounds
-
Latest Funding Round
$27 M (USD), Series C
Jul 11, 2004
-
Investors
The Carlyle Group
& 9 more
-
Employee Count
6139
as on Dec 31, 2021
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Liposonix
Liposonix has successfully raised a total of $37.94M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $27 million completed in July 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Liposonix
Liposonix has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include The Carlyle Group, Solta and Pinnacle Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science & tech focused VC firm investing in companies in the US
|
Locked | Locked | Locked | |
|
Investments are made in life sciences firms across all stages.
|
Locked | Locked | Locked | |
|
Early-stage US healthcare investments are made by Accuitive Medical Ventures.
|
Locked | Locked | Locked |
Investor details for Liposonix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Liposonix
Investment portfolio details for Liposonix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Liposonix
Detailed financials for Liposonix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Liposonix Comparisons
Peer comparison for Liposonix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Liposonix
Liposonix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zeltiq, CoolSculpting, Nitinote Surgical, Standard Bariatrics and HourGlass Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Controlled cooling technology is developed for non-surgical fat reduction.
|
|
| Locked | Locked | Locked |
Non-surgical fat reduction is achieved through controlled-cooling technology.
|
|
| Locked | Locked | Locked |
Non-surgical bariatric solutions for obesity are developed.
|
|
| Locked | Locked | Locked |
Medical devices for obesity surgical treatment are provided.
|
|
| Locked | Locked | Locked |
Weight-loss solutions are developed via incision-free transoral procedures.
|
Detailed competitors of Liposonix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Liposonix
Complete news archive for Liposonix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Liposonix
Liposonix was founded in 1999 and raised its 1st funding round 3 years after it was founded.
Liposonix is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Liposonix is a funded company, having raised a total of $37.94M across 3 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Liposonix is 6,139.
Annual revenue of Liposonix is $9.52B as on Dec 31, 2024.
Liposonix was founded in 1999 in Hayward, United States, within the medical aesthetics sector. Non-surgical systems are developed by the company to reduce fat in the waist and abdomen using high-frequency ultrasound waves applied externally. The Liposonix System is utilized for targeting fat tissue without invasion. Acquisition by Medicis Technologies Corporation occurred in 2008 for 300 million, with Medicis operating as a subsidiary of Solta Medical, Inc.
Liposonix's top competitors include Nitinote Surgical, CoolSculpting and Standard Bariatrics.
Liposonix has 10 investors. Key investors include The Carlyle Group, Solta, Pinnacle Ventures, Medicis Pharmaceutical, and Three Arch Partners.